Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Paxlovid was given as treatment of COVID-19/My COVID symptoms relapsed about 3 days after feeling better; This spontaneous case was reported by a non-health professional and describes the occurrence of COVID-19 (Paxlovid was given as treatment of COVID-19/My COVID symptoms relapsed about 3 days after feeling better) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Hypertension.    On 04-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Paxlovid was given as treatment of COVID-19/My COVID symptoms relapsed about 3 days after feeling better). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 15-May-2022 to 19-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (Paxlovid was given as treatment of COVID-19/My COVID symptoms relapsed about 3 days after feeling better) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications details were reported by the reporter.  The patient did not received any other medications or products within 2 weeks of starting COVID-19 treatment. It was reported that patient had COVID symptoms relapsed about 3 days after feeling better. Device date:30-May-2022. Company comment: This spontaneous case concerns a patient with unspecified age and gender with no relevant medical history, who experienced the unexpected non-serious adverse events of special interest, COVID-19 (Paxlovid was given as treatment of COVID-19/My COVID symptoms relapsed about 3 days after feeling better) which occurred on unspecified day after a dose of mRNA-1273 vaccine (dose number not specified). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 15-May-2022 to 19-May-2022 for COVID-19 treatment. It was reported that patient had COVID symptoms relapsed about 3 days after feeling better. Ongoing Covid 19 pandemic could be considered as confounder to the event. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement.; Sender's Comments: This spontaneous case concerns a patient with unspecified age and gender with no relevant medical history, who experienced the unexpected non-serious adverse events of special interest, COVID-19 (Paxlovid was given as treatment of COVID-19/My COVID symptoms relapsed about 3 days after feeling better) which occurred on unspecified day after a dose of mRNA-1273 vaccine (dose number not specified). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 15-May-2022 to 19-May-2022 for COVID-19 treatment. It was reported that patient had COVID symptoms relapsed about 3 days after feeling better. Ongoing Covid 19 pandemic could be considered as confounder to the event. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement.